Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-20-033060
Filing Date
2020-07-22
Accepted
2020-07-22 16:33:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 abio-424b5.htm 424B5 734885
2 GRAPHIC gpqvywcrcccp000003.jpg GRAPHIC 3017
3 GRAPHIC gpqvywcrcccp000005.jpg GRAPHIC 3073
4 GRAPHIC gpqvywcrcccp000002.jpg GRAPHIC 3871
5 GRAPHIC gpqvywcrcccp000004.jpg GRAPHIC 2922
6 GRAPHIC gpqvywcrcccp000001.jpg GRAPHIC 2922
  Complete submission text file 0001564590-20-033060.txt   758623
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238067 | Film No.: 201041811
SIC: 2835 In Vitro & In Vivo Diagnostic Substances